JP2022547993A5 - - Google Patents
Info
- Publication number
- JP2022547993A5 JP2022547993A5 JP2022515903A JP2022515903A JP2022547993A5 JP 2022547993 A5 JP2022547993 A5 JP 2022547993A5 JP 2022515903 A JP2022515903 A JP 2022515903A JP 2022515903 A JP2022515903 A JP 2022515903A JP 2022547993 A5 JP2022547993 A5 JP 2022547993A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- amyloid
- beta
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025135157A JP2025178565A (ja) | 2019-09-10 | 2025-08-14 | 診断のための新規分子 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19196512.8 | 2019-09-10 | ||
| EP19196512 | 2019-09-10 | ||
| EP20184340.6 | 2020-07-06 | ||
| EP20184340 | 2020-07-06 | ||
| PCT/EP2020/075420 WO2021048324A1 (en) | 2019-09-10 | 2020-09-10 | Novel molecules for diagnosis |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025135157A Division JP2025178565A (ja) | 2019-09-10 | 2025-08-14 | 診断のための新規分子 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022547993A JP2022547993A (ja) | 2022-11-16 |
| JP2022547993A5 true JP2022547993A5 (https=) | 2023-09-19 |
Family
ID=72356005
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022515903A Pending JP2022547993A (ja) | 2019-09-10 | 2020-09-10 | 診断のための新規分子 |
| JP2025135157A Pending JP2025178565A (ja) | 2019-09-10 | 2025-08-14 | 診断のための新規分子 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025135157A Pending JP2025178565A (ja) | 2019-09-10 | 2025-08-14 | 診断のための新規分子 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230034474A1 (https=) |
| EP (1) | EP4028127A1 (https=) |
| JP (2) | JP2022547993A (https=) |
| KR (1) | KR20220087439A (https=) |
| CN (1) | CN114650866B (https=) |
| AU (1) | AU2020347483A1 (https=) |
| CA (1) | CA3149837A1 (https=) |
| IL (1) | IL291224A (https=) |
| MX (1) | MX2022002873A (https=) |
| WO (1) | WO2021048324A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN121002061A (zh) * | 2023-01-12 | 2025-11-21 | 弗吉尼亚大学专利基金委员会 | 抗cith3抗体及其用途 |
| WO2025134068A1 (en) | 2023-12-22 | 2025-06-26 | Ac Immune Sa | Antibody drug conjugates targeting proteinopathies, and uses thereof |
| CN117567635B (zh) * | 2024-01-16 | 2024-05-14 | 恺佧生物科技(上海)有限公司 | 抗Cas9酶的抗体及其应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030068316A1 (en) * | 1997-02-05 | 2003-04-10 | Klein William L. | Anti-ADDL antibodies and uses thereof |
| US6750324B1 (en) * | 1997-12-02 | 2004-06-15 | Neuralab Limited | Humanized and chimeric N-terminal amyloid beta-antibodies |
| US7811563B2 (en) * | 2004-10-25 | 2010-10-12 | Northwestern University | Anti-addl antibodies and uses thereof |
| NZ581835A (en) * | 2007-06-12 | 2012-09-28 | Ac Immune Sa | Monoclonal anti beta amyloid antibody |
| US20100074901A1 (en) * | 2007-10-15 | 2010-03-25 | Marc Hubert Mercken | Human anti-amyloid antibodies, compositions, methods and uses |
| CN101965365A (zh) * | 2007-10-19 | 2011-02-02 | 伊缪纳斯制药株式会社 | 能够特异性结合Aβ寡聚体的抗体及其应用 |
| JP5599454B2 (ja) * | 2009-08-06 | 2014-10-01 | イムナス・ファーマ株式会社 | Ａβオリゴマーに特異的に結合する抗体およびその利用 |
| JP6027011B2 (ja) * | 2010-10-26 | 2016-11-16 | エーシー イミューン ソシエテ アノニム | 疎水性部分によって修飾されたペプチドを含むリポソームベースの構築物 |
-
2020
- 2020-09-10 US US17/640,656 patent/US20230034474A1/en active Pending
- 2020-09-10 WO PCT/EP2020/075420 patent/WO2021048324A1/en not_active Ceased
- 2020-09-10 MX MX2022002873A patent/MX2022002873A/es unknown
- 2020-09-10 KR KR1020227011571A patent/KR20220087439A/ko active Pending
- 2020-09-10 AU AU2020347483A patent/AU2020347483A1/en active Pending
- 2020-09-10 JP JP2022515903A patent/JP2022547993A/ja active Pending
- 2020-09-10 EP EP20767586.9A patent/EP4028127A1/en active Pending
- 2020-09-10 CA CA3149837A patent/CA3149837A1/en active Pending
- 2020-09-10 CN CN202080077792.6A patent/CN114650866B/zh active Active
-
2022
- 2022-03-09 IL IL291224A patent/IL291224A/en unknown
-
2025
- 2025-08-14 JP JP2025135157A patent/JP2025178565A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11739140B2 (en) | Antibodies specific for hyperphosphorylated tau and methods of use thereof | |
| JP7344797B2 (ja) | 早期バイオマーカーを使用する、ヒト対象における外傷性脳損傷の、超急性の診断及び決定の一助となるための方法 | |
| JP2022166139A (ja) | ユビキチンｃ末端ヒドロラーゼｌ１（ｕｃｈ－ｌ１）およびグリア線維酸性タンパク質（ｇｆａｐ）に対する抗体および関連する方法 | |
| SG188116A1 (en) | Antibody capable of binding specifically to ab-oligomer, and use thereof | |
| JP2020521951A (ja) | 早期バイオマーカーを使用する、頭部への損傷を負ったヒト対象又は負った可能性があるヒト対象に対して、イメージングを実施するかどうかの決定の一助となるための方法 | |
| TW201607956A (zh) | 人類化抗－ｔａｕ抗體 | |
| TW201827467A (zh) | 焦穀胺酸類澱粉蛋白－β之抗體及其用途 | |
| JP2015505665A5 (https=) | ||
| WO2020106598A1 (en) | Tau peptide antigens and antibodies binding thereto for the treatment of tauopathies | |
| JP2022547993A5 (https=) | ||
| CN116348769A (zh) | 用于检测tau蛋白病或淀粉样蛋白形成性疾病的基于血液的测定 | |
| WO2012021475A2 (en) | ANTI-N3pGlu AMYLOID BETA PEPTIDE ANTIBODIES AND USES THEREOF | |
| TWI734279B (zh) | 抗α-突觸核蛋白抗體及其用途 | |
| US20230034474A1 (en) | Novel Molecules for Diagnosis | |
| JP2020526745A (ja) | 血液中のユビキチンカルボキシ末端ヒドロラーゼｌ１レベルを測定するための、改善された方法 | |
| TW202434629A (zh) | 以抗類澱粉β (ABETA)抗體治療神經病症之方法 | |
| CN118973710A (zh) | 用于测定血液样品中的uch-l1、gfap和其他生物标志物的系统和方法 | |
| CA3240822A1 (en) | Systems and methods for determining uch-l1, gfap, and other biomarkers in blood samples | |
| WO2025037271A1 (en) | Plasma assay for detecting cns-derived tau peptides | |
| US20190247503A1 (en) | Methods for treating relapsing forms of multiple sclerosis | |
| WO2026033422A1 (en) | Methods to evaluate early-stage pre-tangle tau aggregates and treatment of alzheimer's disease | |
| HK40020584A (en) | Methods for aiding in the determination of whether to perform imaging on a human subject who has sustained or may have sustained an injury to the head using early biomarkers | |
| NZ625217A (en) | Use of an anti-α-synuclein antibody to diagnose an elevated level of α-synuclein in the brain |